NCNA

Nucana plc is a clinical-stage biopharmaceutical company focused on developing anti-cancer medicines using its proprietary phosphoramidate technology. The company aims to improve treatment outcomes for cancer patients by creating more effective and safer therapies. Nucana's product pipeline includes investigational drugs such as NUC-7738 and NUC-3373, which are designed to enhance the standards of care across various cancer types. The company operates primarily in the oncology sector and is based in the UK and the US.